George Hu's most recent trade in Atrium Therapeutics Inc. was a trade of 60,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 20, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Atrium Therapeutics Inc | Steven George Hughes | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Atrium Therapeutics Inc | Steven George Hughes | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 30,000 | 73,097 | - | 0 | Common Stock | |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Feb 2026 | 115,857 | 0 | - | - | Common Stock | |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Feb 2026 | 74,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Feb 2026 | 73,342 | 0 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Feb 2026 | 68,458 | 0 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Feb 2026 | 50,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Feb 2026 | 49,333 | 0 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 72.45 per share. | 21 Jan 2026 | 2,878 | 31,599 | - | 72.4 | 208,511 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 72.45 per share. | 21 Jan 2026 | 2,017 | 34,477 | - | 72.5 | 146,132 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 72.23 per share. | 07 Jan 2026 | 2,373 | 36,494 | - | 72.2 | 171,402 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 47.54 per share. | 22 Oct 2025 | 2,209 | 38,867 | - | 47.5 | 105,015 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Oct 2025 | 2,209 | 68,458 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.16 per share. | 22 Oct 2025 | 2,209 | 41,076 | - | 10.2 | 22,443 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.16 per share. | 22 Sep 2025 | 2,208 | 41,075 | - | 10.2 | 22,433 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Sep 2025 | 2,208 | 70,667 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 40.58 per share. | 22 Sep 2025 | 2,208 | 38,867 | - | 40.6 | 89,601 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.57 per share. | 15 Sep 2025 | 1,542 | 40,409 | - | 6.6 | 10,131 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2025 | 1,542 | 49,333 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 45.41 per share. | 15 Sep 2025 | 1,542 | 38,867 | - | 45.4 | 70,022 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Aug 2025 | 2,208 | 72,875 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 46.40 per share. | 22 Aug 2025 | 2,208 | 38,867 | - | 46.4 | 102,462 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.16 per share. | 22 Aug 2025 | 2,208 | 41,075 | - | 10.2 | 22,433 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2025 | 1,542 | 50,875 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.57 per share. | 13 Aug 2025 | 1,542 | 40,409 | - | 6.6 | 10,131 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 46.66 per share. | 13 Aug 2025 | 1,542 | 38,867 | - | 46.7 | 71,950 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 42.74 per share. | 06 Aug 2025 | 33,983 | 38,867 | - | 42.7 | 1,452,342 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2025 | 17,667 | 75,083 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 42.74 per share. | 06 Aug 2025 | 17,667 | 72,850 | - | 42.7 | 755,040 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.16 per share. | 06 Aug 2025 | 17,667 | 90,517 | - | 10.2 | 179,497 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2025 | 12,334 | 52,417 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 42.74 per share. | 06 Aug 2025 | 12,334 | 72,850 | - | 42.7 | 527,122 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.57 per share. | 06 Aug 2025 | 12,334 | 85,184 | - | 6.6 | 81,034 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2025 | 11,283 | 73,342 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 42.74 per share. | 06 Aug 2025 | 11,283 | 72,850 | - | 42.7 | 482,205 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.96 per share. | 06 Aug 2025 | 11,283 | 84,133 | - | 16.0 | 180,077 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2025 | 6,167 | 74,000 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 42.74 per share. | 06 Aug 2025 | 6,167 | 72,850 | - | 42.7 | 263,561 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.47 per share. | 06 Aug 2025 | 6,167 | 79,017 | - | 22.5 | 138,572 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 31.06 per share. | 20 Mar 2025 | 9,578 | 72,850 | - | 31.1 | 297,491 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 28.59 per share. | 21 Jan 2025 | 2,032 | 82,428 | - | 28.6 | 58,096 | Common Stock |
| Avidity Biosciences Inc | George Steven Hughes | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 28.60 per share. | 21 Jan 2025 | 1,915 | 84,460 | - | 28.6 | 54,760 | Common Stock |
| Avidity Biosciences Inc | Hughes George Steven | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | George Hughes Steven | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 25,000 | 86,375 | - | 0 | Common Stock | |
| Yelp Inc | George Hu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 5,720 | 30,974 (0%) | 0% | 0 | Common Stock | |
| Yelp Inc | George Hu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 5,682 | 25,254 (0%) | 0% | 0 | Common Stock | |
| Twilio Inc (Class A) | George Hu | Strategic Advisor | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2021 | 12,608 | 7,858 | - | - | Employee Stock Option (right to buy) | |
| Twilio Inc (Class A) | George Hu | Strategic Advisor | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.72 per share. | 11 Nov 2021 | 12,608 | 98,870 (0%) | 0% | 31.7 | 399,926 | Class A Common Stock |
| Twilio Inc (Class A) | George Hu | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 313.85 per share. | 30 Sep 2021 | 380 | 86,711 (0%) | 0% | 313.9 | 119,263 | Class A Common Stock |
| Twilio Inc (Class A) | George Hu | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 312.94 per share. | 30 Sep 2021 | 261 | 87,091 (0%) | 0% | 312.9 | 81,678 | Class A Common Stock |
| Twilio Inc (Class A) | George Hu | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 314.95 per share. | 30 Sep 2021 | 260 | 86,451 (0%) | 0% | 315.0 | 81,887 | Class A Common Stock |
| Twilio Inc (Class A) | George Hu | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 315.82 per share. | 30 Sep 2021 | 129 | 86,322 (0%) | 0% | 315.8 | 40,741 | Class A Common Stock |
| Twilio Inc (Class A) | George Hu | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 311.74 per share. | 30 Sep 2021 | 100 | 87,352 (0%) | 0% | 311.7 | 31,174 | Class A Common Stock |
| Twilio Inc (Class A) | George Hu | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 318.20 per share. | 30 Sep 2021 | 40 | 86,282 (0%) | 0% | 318.2 | 12,728 | Class A Common Stock |
| Twilio Inc (Class A) | George Hu | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 319.00 per share. | 30 Sep 2021 | 20 | 86,262 (0%) | 0% | 319 | 6,380 | Class A Common Stock |
| Twilio Inc (Class A) | George Hu | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 360.33 per share. | 16 Aug 2021 | 1,678 | 87,452 (0%) | 0% | 360.3 | 604,640 | Class A Common Stock |
| Twilio Inc (Class A) | George Hu | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 357.97 per share. | 16 Aug 2021 | 1,090 | 89,130 (0%) | 0% | 358.0 | 390,184 | Class A Common Stock |
| Twilio Inc (Class A) | George Hu | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 355.20 per share. | 16 Aug 2021 | 933 | 90,425 (0%) | 0% | 355.2 | 331,401 | Class A Common Stock |
| Twilio Inc (Class A) | George Hu | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 352.63 per share. | 16 Aug 2021 | 662 | 91,358 (0%) | 0% | 352.6 | 233,444 | Class A Common Stock |
| Twilio Inc (Class A) | George Hu | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 357.13 per share. | 16 Aug 2021 | 205 | 90,220 (0%) | 0% | 357.1 | 73,212 | Class A Common Stock |
| Twilio Inc (Class A) | George Hu | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 351.00 per share. | 16 Aug 2021 | 1 | 92,020 (0%) | 0% | 351 | 351 | Class A Common Stock |